Scholarlink

Purpose of Review <p>Whole blood (WB) transfusion has regained widespread acceptance in trauma resuscitation following its military reemergence and civilian introduction. This review synthesizes the latest evidence evaluating WB in traumatic hemorrhage and identifies key areas for future investigation.</p> Recent Findings <p>Distinct patient subsets derive varying benefits from WB. Recent prospective randomized trials and observational studies indicate a pronounced survival advantage in penetrating trauma, whereas blunt trauma phenotypes exhibit mixed outcomes and potential coagulopathy risks. Females of childbearing potential and pediatric patients are also undergoing reexamination of traditional alloimmunization concerns in light of favorable emerging safety profiles.</p> Summary <p>While prospective trials show mixed mortality outcomes based on injury mechanics, WB consistently demonstrates clear logistical advantages and reduced overall transfusion requirements over component therapy. Blood-banking challenges regarding donor pool optimization, standardized leukoreduction techniques, and shelf-life constraints remain under active scrutiny.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Current Clinical Implications of Whole Blood in Trauma Resuscitation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月30日

查看全文
  • Justin Knittel,
  • Jason R. Gillihan

摘要

Purpose of Review

Whole blood (WB) transfusion has regained widespread acceptance in trauma resuscitation following its military reemergence and civilian introduction. This review synthesizes the latest evidence evaluating WB in traumatic hemorrhage and identifies key areas for future investigation.

Recent Findings

Distinct patient subsets derive varying benefits from WB. Recent prospective randomized trials and observational studies indicate a pronounced survival advantage in penetrating trauma, whereas blunt trauma phenotypes exhibit mixed outcomes and potential coagulopathy risks. Females of childbearing potential and pediatric patients are also undergoing reexamination of traditional alloimmunization concerns in light of favorable emerging safety profiles.

Summary

While prospective trials show mixed mortality outcomes based on injury mechanics, WB consistently demonstrates clear logistical advantages and reduced overall transfusion requirements over component therapy. Blood-banking challenges regarding donor pool optimization, standardized leukoreduction techniques, and shelf-life constraints remain under active scrutiny.